Eli Lilly and Company is recalling a single lot of its Glucagon Emergency Kit for Low Blood Sugar due to potential issues with the product’s potency.
The emergency kits are designed to help treat severe hypoglycemia in both children and adults with severe low blood sugar. According to a complaint the company received, a vial of Glucagon was found in liquid form instead of the expected powder form.
This issue, Eli Lilly noted, “could be related to the manufacturing process” and the product “may fail to treat severe low blood sugar.”
The affected lot is D239382D, and its expiration date is April 2022.
“Lilly is deeply committed to manufacturing high-quality medicines for patients who need them, and the safety and quality of our products is our highest priority,” according to a statement from Eli Lilly. “We take our obligations seriously and have rigorous quality systems in place to ensure compliance with stringent regulatory requirements.”
The FDA also shared this information with consumers on its website.
Michael has more than 16 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.